News and Eventsbiotheryx_admin2021-05-25T13:29:18-07:00

News & Events

BioTheryX Announces First Patient Dosed with BTX-A51 in Phase 1 Clinical Trial in Patients with Advanced Solid Tumors

biotheryx_admin2021-06-09T04:59:45-07:00June 9, 2021|

BioTheryX to Present at the 2021 Jefferies Virtual Healthcare Conference

biotheryx_admin2021-05-25T13:05:18-07:00May 25, 2021|

BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology

biotheryx_admin2021-05-20T09:59:14-07:00May 20, 2021|

BioTheryX Announces Expansion of Scientific Advisory Board with Appointment of Brenda Schulman

biotheryx_admin2021-05-19T15:39:48-07:00May 18, 2021|

BioTheryX to Present at 2021 RBC Capital Markets Global Healthcare Conference

biotheryx_admin2021-05-19T15:46:49-07:00May 4, 2021|

BioTheryX Announces Expansion of Scientific Advisory Board

biotheryx_admin2021-05-19T15:48:53-07:00April 7, 2021|

Events

2021 Jefferies Virtual Healthcare Conference

Tuesday, June 1st, 2021 at 1:30 pm ET
Link: Conference

2021 RBC Capital Markets Global Healthcare Conference

Thursday, May 20th, 2021 at 12:05 pm ET
Link: BioTheryX, Inc. (on24.com)

Credit Suisse Solebury Trout Healthcare Innovators Private Company Showcase

Thursday, March 11, 2021, 12:20 pm PST

Barclays Global Healthcare Conference

Tuesday, March 9, 2021, 4:10 pm EST

2021 SVB Leerink Global Healthcare Conference

February 23, 2021

North American Protein Degradation Congress

3:00 pm ET on February 23, 2021

BMO BioPharma Spotlight Series: Targeted Protein Degradation and Other Next Gen Protein Technologies

10:30 AM ET on February 18, 2021
https://vimeo.com/513980689/1b43607409

LifeSci Partners Precision Oncology Day

1:00 PM ET on February 17, 2021

Targeted Protein Degradation & PROTAC Symposium

16:30 GMT on February 16, 2021

Oppenheimer Private Life Sciences Company Call Series

8:45AM EDT on August 18, 2020

LifeSci Partners Summer Symposium

August 4th, 2020